NEW YORK (GenomeWeb News) – Eutropics said today that it will use its companion diagnostic methodology to help Tolero Pharmaceuticals develop therapeutics for hematological malignancies.

Under the terms of the agreement, Eutropics will use its Praedicare-Dx biomarker platform to support the development of Tolero's alvocidibm, a Phase III compound that has demonstrated clinical activity in patients with acute myelogenous leukemia and chronic lymphocytic leukemia.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Dog DNA testing finds that some purebreds might not truly be purebreds, Inside Edition reports.

Mary Beckerle has returned as director of the Huntsman Cancer Institute, according to ScienceInsider.

Smithsonian Magazine reports that environmental DNA sampling can be used to track elusive organisms.

In Genome Research this week: repetitive satellite DNA in the fruit fly, transcriptome map assembly pipeline, and more.